HOME > ARCHIVE
ARCHIVE
- Sawai: Strong Sales Showing Makes Company Top GE Maker
June 16, 2003
- Almost No Growth in Domestic Market in Last 10 Years: Mr Yashiro
June 16, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
June 16, 2003
- Sundrug: Sales Top \100 Billion
June 16, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
June 16, 2003
- WORLD NEWS IN BRIEF
June 16, 2003
- Seijo Joins WIN Group
June 16, 2003
- DIAGNOSTIC NEWS IN BRIEF
June 16, 2003
- BULLETIN
June 16, 2003
- Toho: Sales Rise 10.4%, Net Profits Up 148.4%
June 16, 2003
- Semiannual Settlement
June 16, 2003
- Daiichi Suntory Pharma to License Carperitide to Fujisawa Healthcare
June 16, 2003
- New Adverse Reactions to Remicade, Iressa Reported: Safety Info.
June 16, 2003
- MEDICAL DEVICE NEWS IN BRIEF
June 16, 2003
- Restructuring Programs Showing Visible Results:Mr Eiki of Bayer Yakuhin
June 16, 2003
- MOF Presents "viewpoints for Healthcare Reform"
June 16, 2003
- Kyorin to Revise Midterm Plan due to Sluggish Gatiflo Sales
June 16, 2003
- REGULATORY NEWS IN BRIEF
June 16, 2003
- AnGes MG Licenses NF-κB Decoy to Goodman
June 16, 2003
- Matsumotokiyoshi Plans to Acquire Makers
June 16, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
